𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epidemiology of hepatitis C virus in injecting drug users in england and wales: implications for HCV drug therapy

✍ Scribed by A. Judd; M. Hickman; G.V. Stimson; V.D. Hope; O. Gill; J.V. Parry

Book ID
119527292
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
141 KB
Volume
34
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Molecular epidemiology of hepatitis C vi
Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users
✍ Yoann Morice; Jean-FranΓ§ois Cantaloube; StΓ©phanie Beaucourt; Laetitia Barbotte; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 337 KB πŸ‘ 1 views

## Abstract Hepatitis C virus subtype 3a (HCV‐3a) originates from Asia and has spread widely among injecting drug users as well as other patient groups in industrialized countries. HCV subtype 3a infection remains highly prevalent and frequently transmitted in the population of intravenous drug use

Change in hepatitis C virus genotype in
Change in hepatitis C virus genotype in injecting drug users
✍ Campbell Aitken; Rhonda McCaw; Darren Jardine; Scott Bowden; Peter Higgs; Oanh N πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 51 KB πŸ‘ 1 views

## Abstract Six major genotypes of the hepatitis C virus (HCV) have been described; it is assumed to be uncommon for genotypes to change in chronically infected individuals. Venous blood samples obtained from Vietnamese‐Australian injecting drug users who participated in successive studies conducte

Molecular analysis of hepatitis C virus
Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users
✍ Massimo Ciccozzi; Gianni Zehender; Valeria Cento; Alessandra Lo Presti; Pavel Te πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 247 KB πŸ‘ 1 views

## Abstract Intravenous drug users constitute a group at risk for hepatitis C virus (HCV) infection. Today, no data are available on the molecular epidemiology of HCV in Bulgaria despite the fact that in recent years the incidence of acute hepatitis C infection among Bulgarian intravenous drug user